The following table illustrates the impact of ASC 326: (Details) - USD ($) $ in Thousands		Dec. 31, 2023		Dec. 31, 2022		Dec. 31, 2021	Dec. 31, 2020
Loans		$ 2,024,824		$ 1,989,276	[1]
Allowance for credit losses on loans		(20,267)	[2],[3]	(19,931)	[2],[4]	$ (19,787)	$ (21,157)
Deferred tax asset		13,636		15,027
Allowance for credit losses on off-balance sheet exposures		(597)
Retained earnings, net of tax		$ (136,993)		(127,982)
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Loans	[1]			1,991,389
Allowance for credit losses on loans	[4]			(21,113)
Deferred tax asset				15,023
Allowance for credit losses on off-balance sheet exposures				(918)
Retained earnings, net of tax				(127,991)
Cumulative Effect, Period of Adoption, Adjustment [Member]
Loans	[1]			2,113
Allowance for credit losses on loans	[4]			(1,182)
Deferred tax asset				(4)
Allowance for credit losses on off-balance sheet exposures				(918)
Retained earnings, net of tax				$ (9)

[1] Purchase credit deteriorated (“PCD loans”) gross up of cost basis of loans totaled $422,000 for commercial real estate loans and $1,691,000 for commercial and industrial loans.

[2] The Company adopted ASU 2016-13 on January 1, 2023 with a modified retrospective approach. Accordingly, beginning at January 1, 2023, the allowance for credit losses was determined in accordance with ASC 326, “Financial Instruments-Credit Losses.”

[3] The balance of $7.5 million in accrued interest receivable is excluded from amortized cost and the calculation of the allowance for credit losses at December 31, 2023.

[4] Increase to allowance for credit losses on loans of $2,113,000 for PCD loans gross up and a decrease of $931,000 for pooled loans through retained earnings.